Papers
2
Total Citations
17
H-Index
2
About
Yingchao Li is a pioneering surgeon advancing the frontiers of minimally invasive gastrointestinal oncology, with a specific focus on the treatment of gastric submucosal tumors (GSMTs) and gastrointestinal stromal tumors (GISTs). Dr. Li’s major contribution is the development and clinical validation of "Third Space Robotic and Endoscopic Cooperative Surgery" (TS-RECS), a novel technique that merges the precision of robotic surgery with the flexibility of endoscopy. This approach is designed to achieve complete oncological curability while maximizing functional preservation of the stomach, a critical balance in gastric surgery. Dr. Li’s work, including a 2019 study on the clinical feasibility of TS-RECS for GIST dissection (15 citations) and a 2021 propensity score-matched study comparing it to standard laparoscopic wedge resection (2 citations), provides foundational evidence for this innovative procedure. By demonstrating its safety and superior functional outcomes, Dr. Li is establishing a new paradigm for gastric tumor resection, offering patients a less invasive option that better preserves digestive function. This research positions Dr. Li as a key innovator in the evolution of surgical oncology, where the integration of advanced technologies is redefining the standard of care.
Research Focus
Key Achievements
Top Papers
- 1
- 2